In the past decade, an array of publications have demonstrated how CPT1C enables cancer cells to adapt their lipid metabolism to resist stressful conditions such as hypoxia and glucose deprivation [10,13], avoid cellular senescence, and enhance tumorigenesis [12,14,17,22,23]. This evidence concerns the gene CPT1C and cancer.